Ashland

Abstract Polymeric micelles are promising nanocarriers for improving the solubility and therapeutic efficacy of poorly water-soluble drugs. In this study,...

Abstract Background/Objectives: Rutin, a bioactive flavonol glycoside known for its antioxidant, anti-inflammatory, and anticancer activities, faces limited clinical application due...

Abstract Topical dosage forms represent a critical segment of pharmaceutical products, offering localized drug delivery with minimal systemic exposure. This...

CPhI Frankfurt and AAPS PharmSci 360 Review Ashland showed multiple new and optimized pharmaceutical product offerings during CPHI Frankfurt and...

Abstract The tabletability flip phenomenon (TFP), in which a solid form of an active pharmaceutical ingredient (API) with lower inherent...

Abstract This study aimed to develop a scalable, coating-free delayed-release matrix tablet via twin-screw melt granulation (TSMG) using Eudragit® FS100...

Abstract Fenofibric acid (FA), the active metabolite of fenofibrate, is a potent lipid-modifying agent whose clinical effectiveness is often compromised...

The AAPS Annual Meeting 2025 is happening November 9-12, 2025, at the Henry B. Gonzalez Convention Center in San Antonio,...

Abstract Famotidine suffers from low oral bioavailability due to poor aqueous solubility, short half-life, and limited gastric retention. This study...

Abstract Tablets are the most preferred oral dosage form due to advantages such as high-speed manufacturing, cost-effectiveness, stability, and patient...